FDA Inspection 1121216 - CorneaGen - Boston - March 05, 2020

Record Details

This FDA Inspection record concerns CorneaGen - Boston, with an inspection on March 5, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: CorneaGen - Boston
Inspection Date: March 5, 2020
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · f1850371-f861-48c2-b3ae-2c4022fa55f5